Delivery Order SPE2DB22D3016-SPE2DB25FBHV1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a $22,151.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jardiance 10 mg tablets (90-count units). The contract, which is non-set-aside and competitively awarded, will be performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Jardiance 25 mg tablets (90-count supply). This firm fixed-price delivery order, valued at $8,515.11, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract represents a non-competitive, non-set-aside award and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $6,240.97 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 21, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a delivery order valued at $3,200.35 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with a completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,881.52. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for ultimate completion by September 4, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) with a ceiling value of $86,831.47. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a $2,172.97 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 29, 2025, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $51,975.23 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHV1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,646.78 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The DLA Troop Support Medical contract enables the company to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare systems worldwide. This specific delivery order for Jardiance, a diabetes medication, exemplifies the company's role in delivering essential pharmaceutical commodities through the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 9/10/25 |